PT. Glaxo Wellcome Indonesia
Extra Info
Title: Home | GSK
URL Source: http://www.gsk.com/
Markdown Content:
Home | GSK
===============
Global
Switch to dark mode to head towards a more sustainable world together. More info
Healthcare professionals Contact us Search
GSK logo linking to the homepage
Back to main Behind the science magazine
Close menu
Back to main Company
- Company
- Purpose, strategy and culture
Company Outstanding people
- History and heritage
- Board of directors and leadership team
- Board information
Company Governance
- Codes, standards and reports
FEATURED SECTION Our purpose, strategy and culture
FEATURED SECTION Outstanding people 
Close menu
Back to main Innovation
- Innovation
Innovation Our leading scientists
Research and development approach
- Pipeline
Innovation Therapeutic areas
Innovation Clinical trials at GSK
- Provision of unapproved medicines for unmet medical needs
- Data transparency
- Representative clinical studies
Innovation Partnering with GSK
SPOTLIGHT ON Behind the science magazine
Featured section Our leading scientists 
Close menu
Back to main Products
SPOTLIGHT ON Innovation
FEATURED WEBSITE GSKPro for healthcare professionals 
Close menu
Back to main Responsibility
- Responsibility
- Access
Global health and health security
Responsibility Global health and health security
Responsibility Environment
Responsibility Ethical standards
- Working with third parties
- Public policy and patient advocacy
- Human rights
- Use of animals
- Engaging with healthcare professionals
- Charitable investments
Responsibility Responsibility reports
FEATURED SECTION Inclusion
SPOTLIGHT ON Our policy positions 
Close menu
Back to main Investors
- Investors
- Why invest in GSK?
- Quarterly results
Investors Financial reports
- Speeches and presentations
- Science publications
- Events calendar
Investors Dividend and share price
Investors Stock exchange announcements
Investors Shareholder information
- Manage your shares
- Annual General Meeting
- General Meeting
- Annual Governance Meeting
- Corporate sponsored nominee service
- Our ADR programme
- Asset reunification - Georgeson
- Share scam alert
- Privacy notice for ordinary shareholders
- FAQs
Investors Corporate actions
- Investor contacts
SPOTLIGHT ON Press releases
SPOTLIGHT ON Our pipeline 
Close menu
Back to main Media
- Media
- Press release archive
- Media contacts
- Conferences
- Media library
- Our response to the situation in Ukraine
- Our response to the crisis in Israel and Gaza
- Zantac litigation
- Our social media
- RSS feeds
Spotlight on Behind the science magazine
Featured section Conferences 
Close menu
Back to main Careers
- Careers
- Search jobs
Careers Featured careers
Careers Experienced professionals
- Business operations
- Engineering at GSK
- Manufacturing and supply
- Marketing and sales
Experienced professionals Research and development
Careers Early careers
- Application process
- Apprentice programmes
- Internships and placements
Early careers Graduate programme
- Business operations
- Engineering
- Manufacturing operations, Quality, Supply chain, Environment health & safety (EHS)
- Commercial
- Research and development
- Digital & tech
- Manufacturing sciences & technology
- Frequently asked questions
- Our global and regional hubs
Careers How we hire
Spotlight on Outstanding people
Spotlight on Inclusion Close menu
Switch to dark mode to head towards a more sustainable world together. More info
- Contact us
Investors
2024 Annual Report and Responsible Business Performance Report
Read about our strong performance and pipeline momentum in 2024.
Annual Report 2024 Responsibility reports
Our purpose
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.Our R&D focus is on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases.
Respiratory, immunology and inflammation
70m
deaths each year due to lung diseases
Go to respiratory, immunology and inflammation
Oncology
~10m
people died from cancer in 2022, making it a leading cause of death worldwide
HIV
40m
people living with HIV globally
Infectious diseases
1 in 6
deaths globally caused by infectious disease
Behind the science
Discover how we're getting ahead
### ‘This could be a golden moment’: Is prevention the ‘medicine’ we need to end the HIV epidemic?
### Remission could be possible for people with asthma, giving them a new outlook on life
### ‘We’ve seen an explosion in computing power’: Using AI, machine learning and data to unlock the mysteries of disease
### ‘Patients can breathe easier today’: Scientific advances in asthma and COPD care could prevent irreversible lung damage
### Advanced technology is increasing the chances of improving outcomes for cancer patients
### Robots, AI, and machine learning: how smart manufacturing is getting medicines and vaccines from factories to patients faster
Life at GSK
Find out what it's like to work with us
Make a difference with us
With our innovation, scale and global partnerships, working with us presents a unique opportunity to impact the lives of billions.
Do your best work with us
To get ahead of disease together, continuous growth and development are vital. At GSK you'll expand your skills and build valuable connections, enabling you to do your best work.
Hear what Sarah and Martha have to say
Be yourself with us
We've built an inclusive and supportive culture, so that you can pursue your professional goals without compromising on what matters most.
Positively impacting society and the planet
Access
We are making our products affordable and available to more people around the world through responsible pricing, strategic access programmes and partnerships.
Global health and health security
We are committed to change the trajectory of high burden diseases in lower-income countries with a focus on prevention and treatment of infectious diseases.
Global health and health security
Environment
We're committed to work towards a net zero, nature positive, healthier planet, with ambitious goals set for 2030 and 2045.
Inclusion
To be a successful business and deliver positive health impact at scale, we must meet patients’ needs with research that includes those impacted by the disease under study, attract and retain the best talent regardless of background, and support all GSK people to thrive.
Ethical standards
Our culture guides our people to do the right thing and act on any concerns they have.
Product governance
Ensuring the quality, safety and reliable supply of our products is critical to our purpose of uniting science, talent and technology to get ahead of disease together.
London
1,461.00 GBp -6.00
Share price at 27 February 2025 17:18
NYSE
37.30 USD -0.10
Share price at 27 February 2025 16:00
INVESTORS
We announced our full year and fourth quarter 2024 results on Wednesday 5 February
GSKThis is our global website, intended for visitors seeking information on GSK's worldwide business. Our market sites can be reached by visiting our location selector.
© 2001-2024 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies.
GSK plc. Registered in England and Wales No. 3888792.
Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG
> Modern Slavery Act Statement 2024 (PDF - 162.5KB)
- GSK websites
- Locations selector
- Social media directory
- GSKPro for healthcare professionals
- GSK study register
- Supplier website
Quick links
- Behind the science magazine
- Company
- Innovation
- Products
- Responsibility
- Investors
- Media
Get in touch
- Contact us
- Partnerships
- Report a possible side effect
- GSK Speak up
Follow us on:
- Digital sustainability
- Terms of use
- Cookie policy
- Privacy notice
- Sitemap